Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 2-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject did not have medical history. On an unspecified date, the subject received 1st dose of ROTARIX (1 ml, oral). On 12 December 2008, at an unspecified time after vaccination with ROTARIX, the subject experienced diarrhea and abdominal distention. On 19 December 2008, the subject presented abdominal distension and intestinal ileus. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed and did not showed a visible intussusceptum of soft tissue mass. The exam showed fluid levels and dilated bowel loops. The demonstration of invagination of the intestine by air or liquid contrast enema was not done. The plain abdominal x-Ray showed non-specific abnormalities. The abdominal x-Ray showed bad intestinal distribution and intestinal distension, suspicious ileosileal intussusception which was confirmed and resolved by laparotomy and taxis on 21 December 2008. After the surgery, the subject presented pulmonary collapse, septic shock, anemia and need of transfusion. The subject required intensive unit care and was transfered to another hospital. The physician does not have complete dossier and does not have more data. At the time of reporting the outcome of the events was unspecified. It was not known if the subject survived.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166